Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Small Cell Lung Carcinoma 4Neuroectodermal Tumors, Primitive, Peripheral 4Unspecified Adult Solid Tumor, Protocol Specific 2Sarcoma 2Rhabdomyosarcoma 2Medulloblastoma 2Carcinoma, Ovarian Epithelial 2Wilms Tumor 1Testicular Neoplasms 1Sarcoma, Ewing 1Retinoblastoma 1Recurrence 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Neuroblastoma 1Meningeal Carcinomatosis 1Malignant mesenchymal tumor 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Familial ependymoma 1Dendritic Cell Sarcoma, Interdigitating 1Congenital Abnormalities 1Burkitt Lymphoma 1Brenner Tumor 1Brain Neoplasms 1

Interventions

Paclitaxel 25Carboplatin 22Taxes 16Bevacizumab 10Cisplatin 8Immunoglobulin G 7Disulfides 7Topotecan 3Platinum 3Docetaxel 31,2-diaminocyclohexaneplatinum II citrate 3paclitaxel poliglumex 2VTX-2337 2SS1(dsFv)PE38 2Peripheral Blood Stem Cell Transplantation 2Gemcitabine 2Filgrastim 2Etoposide 2Erlotinib Hydrochloride 2Chemotherapy, Adjuvant 2veliparib 1trioctyl phosphine oxide 1sargramostim 1pegfilgrastim 1liposomal doxorubicin 1emactuzumab 1elesclomol 1dexamethasone acetate 1dexamethasone 21-phosphate 1belinostat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brenner Tumor × trioctyl phosphine oxide × Clear all
NCT00002913 2013-01-24

Paclitaxel, Cisplatin, and Topotecan With or Without Filgrastim in Treating Patients With Newly Diagnosed Stage III or Stage IV Epithelial Ovarian Cancer

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Brenner Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡